← Leaderboards
Qinglan Ling
Ut Southwestern Medical Center
$676,511
Attributed
$676,511
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$676,511 · 2
By mechanism
R00$494,217 · 1
K99$182,294 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Jennifer Helene Stern$2,679,968
- Cameron Joseph Menezes$80,662
- Andreas C Chai$83,233
- Samuel Kent McBrayer$5,142,431
- Qian Lin$148,575
Others in their field
Other Rising Stars on “Cre Driver”
- Dawid Grzegorz Nowak · Weill Medical Coll Of Cornell Univ$1,899,979
- Daria Esterhazy · University Of Chicago$1,402,897
- Dhananjay Yellajoshyula · Case Western Reserve University$1,347,887
- David W Gludish · Cornell University$1,047,417
- Thomas Urban Marron · Icahn School Of Medicine At Mount Sinai$971,034
- Theanne Nicole Griffith · University Of California At Davis$968,264
Research focus
Cre DriverComplex IvAtp PhosphohydrolaseAdeno-Associated Viral VectorAnimal ModelBase EditingBase EditorBehavioralAtp Synthesis PathwayBiologyBrainCareerCareer DevelopmentCell Culture TechniquesCell GrowthCell LineCell NucleusCell PhysiologyBiochemicalClinical TrialsCodeCodon NucleotidesComplementCre-Loxp
Grant awards (4)
First murine animal model and adeno-associated virus (AAV)-based gene therapy for MTATP6 mitochondrial diseases$245,217
R00 · FY2025 · HD · contact PI
First murine animal model and adeno-associated virus (AAV)-based gene therapy for MTATP6 mitochondrial diseases$249,000
R00 · FY2024 · HD · contact PI
First murine animal model and adeno-associated virus (AAV)-based gene therapy for MTATP6 mitochondrial diseases$91,147
K99 · FY2023 · HD · contact PI
First murine animal model and adeno-associated virus (AAV)-based gene therapy for MTATP6 mitochondrial diseases$91,147
K99 · FY2022 · HD · contact PI